Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- N/A
Select oil/gas related names showing early weakness:
- SU -0.8%, RDS.A -0.6%, BP -0.6%, OXY -0.5%, RIG -0.5%
Other news:
- ITEK -47.8% (announces 'no meaningful clinical advantage in IOP reduction' from its Phase 2 trial of trabodenoson and latanoprost for the treatment of glaucoma, announces it is exploring strategic alternatives)
- NXTD -12.8% (enters into definitive agreements with existing institutional investors to purchase an aggregate of approximately $3,432,000 of shares of common stock in a registered direct offering and common stock purchase warrants in a concurrent private)
- USAT -3.8% (files for $40 mln offering of common stock)
- LUV -1.7% (June Traffic)
- SHPG -1.5% (obtained a preliminary injunction in a court of Hamburg against Roche (RHHBY) to address incomplete and misleading statements regarding Emicizumab)
- COOL -0.7% (files for $100 mln mixed securities shelf offering)
Analyst comments:
- KBH -2.3% (downgraded to Underperform at Mizuho)
- INTC -1.6% (downgraded to Underperform from Hold at Jefferies)
- COST -0.7% (downgraded to Market Perform from Outperform at BMO Capital)
- SUN -0.7% (downgraded to Underperform at Mizuho)